title: [Predementia Alzheimer's disease. Benefits of early diagnosis].
abstract: Given population aging and the rise in the number of persons with Alzheimer's disease, measures that aim not only to delay but also to prevent the development of this disease are increasingly required. Advances in the diagnosis of Alzheimer's disease support the need for a review of current clinical standards for mild cognitive impairment and provide new goals in the early treatment of this disease. The current diagnostic process should be refocussed toward the pathological substrate of this disease rather than symptoms in order to initiate therapeutic measures as soon as possible without waiting for clinical manifestations to appear. Such an approach is essential in patients with greater cognitive reserve, in whom the lesions are usually more severe at diagnosis and treatment is less effective. To identify disease-modifying therapies to delay the onset of the clinical symptoms of Alzheimer's disease in cognitively intact persons at high risk, biomarkers for this disease must be validated. A single biomarker is unlikely to provide the required diagnostic accuracy and therefore a multimodal approach, incorporating biochemical, neuropathological and anatomical and metabolic neuroimaging methods, should be employed. To optimize the results of drugs under investigation, a combination of biomarkers should be used to select appropriate participants in the earliest phases of the disease, and disease progression should be followed-up. Early diagnosis might clarify essential questions in the care of patients with Alzheimer's disease, such as the possibility of distinguishing among various subtypes, thus encouraging the development of optimal treatments for each. The ultimate goal is to develop disease-modifying treatments that could be initiated early, while patients are asymptomatic or only minimally symptomatic, to maintain their quality of life.
authors.affiliation: Unidad de Memoria, Servicio de Geriatría, Hospital Clínico San Carlos, Madrid, España. auviji@yahoo.com
authors.forename: Aurora
authors.initials: A
authors.lastname: Viloria
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis*; D015415:Biomarkers / Q000032:analysis; D039721:Diagnostic and Statistical Manual of Mental Disorders; D018450:Disease Progression; D042241:Early Diagnosis; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D015415:Biomarkers